Correction to Involvement of H2S, NO and BDNF-TrkB signalling pathway in the protective effects of simvastatin against pentylenetetrazole-induced kindling and cognitive impairments in mice

IF 2.7 4区医学 Q2 PHARMACOLOGY & PHARMACY

Basic & Clinical Pharmacology & Toxicology Pub Date : 2024-05-16 DOI:10.1111/bcpt.14016

{"title":"Correction to Involvement of H2S, NO and BDNF-TrkB signalling pathway in the protective effects of simvastatin against pentylenetetrazole-induced kindling and cognitive impairments in mice","authors":"","doi":"10.1111/bcpt.14016","DOIUrl":null,"url":null,"abstract":"\n Marwa A. Ahmed, Esam O. Kamel. Involvement of H2S, NO and BDNF-TrkB signalling pathway in the protective effects of simvastatin against pentylenetetrazole-induced kindling and cognitive impairments in mice. Basic Clin Pharmacol Toxicol. (2020); 127(6): 460–476. doi:10.1111/bcpt.13457In the results section of the above article, duplications of subfigures was found in Figure 6C,D, Figure 6I,K, and Figure 7C,D. The senior authors were not aware of the errors in the figure. Therefore, the figures have now been replaced.After replacement of the wrong figures with the new corrected figures, legends are the same because there are no new depicted features and so the captions are the same, too. In addition, these new corrected figures do not affect the results or discussion and so they do not affect the final conclusion of the manuscript.Below are the correct figures.The authors apologize for this error.","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":"135 1","pages":"109-111"},"PeriodicalIF":2.7000,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bcpt.14016","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.14016","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

Abstract

Marwa A. Ahmed, Esam O. Kamel. Involvement of H₂S, NO and BDNF-TrkB signalling pathway in the protective effects of simvastatin against pentylenetetrazole-induced kindling and cognitive impairments in mice. Basic Clin Pharmacol Toxicol. (2020); 127(6): 460–476. doi:10.1111/bcpt.13457

In the results section of the above article, duplications of subfigures was found in Figure 6C,D, Figure 6I,K, and Figure 7C,D. The senior authors were not aware of the errors in the figure. Therefore, the figures have now been replaced.

After replacement of the wrong figures with the new corrected figures, legends are the same because there are no new depicted features and so the captions are the same, too. In addition, these new corrected figures do not affect the results or discussion and so they do not affect the final conclusion of the manuscript.

Below are the correct figures.

The authors apologize for this error.

Abstract Image

查看原文本刊更多论文

更正为辛伐他汀对戊四唑诱导的小鼠木僵和认知障碍的保护作用中H2S、NO和BDNF-TrkB信号通路的参与。

Marwa A. Ahmed, Esam O. Kamel. 辛伐他汀对戊四唑诱导的小鼠点燃和认知障碍的保护作用中H2S、NO和BDNF-TrkB信号通路的参与。Basic Clin Pharmacol Toxicol.(2020); 127(6): doi:10.1111/bcpt.13457在上述文章的结果部分，发现图6C,D、图6I,K和图7C,D中的子图重复。资深作者没有注意到图中的错误。在用新的更正图替换错误图之后，图例是一样的，因为没有新的特征描述，所以标题也是一样的。此外，这些新的更正图并不影响结果或讨论，因此也不影响手稿的最终结论。以下是正确的图，作者对此错误深表歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Basic & Clinical Pharmacology & Toxicology 医学-毒理学

CiteScore

5.60

自引率

6.50%

发文量

126

审稿时长

1 months

期刊介绍： Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.